Cited by 89Hepatocellular Carcinoma Treatment and PrognosisGlobal Cancer Incidence and ScreeningHealth Promotion and Cardiovascular Prevention

Mailed outreach invitations significantly improve HCC surveillance rates in patients with cirrhosis: a randomized clinical trial

Open access
Singal, Amit G., Tiro, Jasmin A., Murphy, Caitlin C., Marrero, Jorge A., McCallister, Katharine, Fullington, Hannah, Mejias, Caroline, Waljee, Akbar K. +3 more·2019·Hepatology

Abstract

Hepatocellular carcinoma (HCC) surveillance is associated with early tumor detection and improved survival in patients with cirrhosis; however, effectiveness is limited by underuse. We compared the effectiveness of mailed outreach and patient navigation strategies to increase HCC surveillance in a racially diverse cohort of patients with cirrhosis. We conducted a pragmatic randomized clinical trial comparing mailed outreach for screening ultrasound (n = 600), mailed outreach plus patient navigation (n = 600), or usual care with visit‐based screening (n = 600) among 1800 patients with cirrhosis at a large safety‐net health system from December 2014 to March 2017. Patients who did not respond to outreach invitations within 2 weeks received reminder telephone calls. Patient navigation included an assessment of barriers to surveillance and encouragement of surveillance participation. The primary outcome was HCC surveillance (abdominal imaging every 6 months) over an 18‐month period. All 1800 patients were included in intention‐to‐screen analyses. HCC surveillance was performed in 23.3% of outreach/navigation patients, 17.8% of outreach‐alone patients, and 7.3% of usual care patients. HCC surveillance was 16.0% (95% confidence interval [CI]: 12.0%‐20.0%) and 10.5% (95% CI: 6.8%‐14.2%) higher in outreach groups than usual care (P < 0.001 for both) and 5.5% (95% CI: 0.9%‐10.1%) higher for outreach/navigation than outreach alone (P = 0.02). Both interventions increased HCC surveillance across predefined patient subgroups. The proportion of HCC patients detected at an early stage did not differ between groups; however, a higher proportion of patients with screen‐detected HCC across groups had early‐stage tumors than those with HCC detected incidentally or symptomatically (83.3% versus 30.8%, P = 0.003). Conclusion: Mailed outreach invitations and navigation significantly increased HCC surveillance versus usual care in patients with cirrhosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.30129

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The survey was limited by nonresponse bias, although the response rate is similar to those of similar mailed efforts.

    “our survey was limited by nonresponse bias, although our response rate is similar to those of similar mailed efforts.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 39 · Cited by 89

Authors
Singal, A. G., Tiro, J. A., Murphy, C. C., Marrero, J. A., McCallister, K., Fullington, H., Mejias, C., Waljee, A. K., Pechero Bishop, W., Santini, N. O., & Halm, E. A.
Affiliations
  • Parkland Health & Hospital System (US)
  • Harold C. Simmons Comprehensive Cancer Center (US)
  • The University of Texas Southwestern Medical Center (US)
  • University of Michigan (US)
  • Department of Clinical Sciences,The University of Texas Southwestern Medical Center,Dallas,Texas
Corresponding author
Singal, Amit G.
Venue
Hepatology
Published
2018-12-14
Volume
69
Issue
1
Pages
121-130
ISSN
  • 0270-9139 (ISSN-L)
  • 1527-3350
OpenAlex
W2886194374
Cited by
89
References
39
Citations by year
2026: 6 · 2025: 9 · 2024: 16 · 2023: 12 · 2022: 8 · 2021: 11 · 2020: 18 · 2019: 9
FWCI
5.95
Type
journal article
Language
en
Open access
Locations
  • Hepatology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Deep Blue (University of Michigan) (submittedVersion)
Funders
  • Cancer Prevention and Research Institute of Texas (RP150587)
  • National Institutes of Health (RP150587)
  • Agency for Healthcare Research and Quality (P30 CA142543, HS022418, R24HS022418, NIH RO1 CA212008)
  • National Cancer Institute (R24 HS022418, RP150587, RO1CA212008, R01CA212008, (CA142543), P30CA142543)
Topics
  • Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
Keywords
HCC surveillance, liver cirrhosis, patient navigation, early cancer detection, safety-net health system
MeSH terms
Adult, Aged, Aged, 80 and over, Double-Blind Method, Female, Carcinoma, Hepatocellular, Humans, Liver Cirrhosis, Liver Neoplasms, Male, Middle Aged, Population Surveillance, Postal Service, Ultrasonography, Early Detection of Cancer, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review